PeptideDB

Tetrabutylammonium (fluoride) (TBAF) 429-41-4

Tetrabutylammonium (fluoride) (TBAF) 429-41-4

CAS No.: 429-41-4

Tetrabutylammonium fluoride is a biochemical compound that could be utilized as a biomaterial or organic/chemical reagen
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Tetrabutylammonium fluoride is a biochemical compound that could be utilized as a biomaterial or organic/chemical reagent for biomedical research.

Physicochemical Properties


Molecular Formula C16H36FN
Molecular Weight 261.46
Exact Mass 261.283
CAS # 429-41-4
Related CAS # 10549-76-5 (Parent)
PubChem CID 2724141
Appearance Colorless to light yellow liquid
Density 0.887
Melting Point 62-63 °C(lit.)
Flash Point -17 ºC
Index of Refraction n20/D 1.456
LogP 2.007
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 1
Rotatable Bond Count 12
Heavy Atom Count 18
Complexity 116
Defined Atom Stereocenter Count 0
SMILES

CCCC[N+](CCCC)(CCCC)CCCC.[F-]

InChi Key FPGGTKZVZWFYPV-UHFFFAOYSA-M
InChi Code

InChI=1S/C16H36N.FH/c1-5-9-13-17(14-10-6-2,15-11-7-3)16-12-8-4;/h5-16H2,1-4H3;1H/q+1;/p-1
Chemical Name

tetrabutylazanium;fluoride
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Additional Infomation Tetrabutylammonium fluoride is a fluoride salt and a tetrabutylammonium salt. It has a role as a phase-transfer catalyst.

Solubility Data


Solubility (In Vitro) DMSO: 100 mg/mL (382.47 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (9.56 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (9.56 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.8247 mL 19.1234 mL 38.2468 mL
5 mM 0.7649 mL 3.8247 mL 7.6494 mL
10 mM 0.3825 mL 1.9123 mL 3.8247 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.